Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14913-14920
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14913
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14913
Patient group | MUC1 | MUC4 | MUC17 | SNA | ECA | |||||
Surface foveola cell | Gland cell | Surface foveola cell | Gland cell | Surface foveola cell | Gland cell | Surface foveola cell | Gland cell | Surface foveola cell | Gland cell | |
H. pylori+/NSAID- | 2.93 ± 5.13 | 2.57 ± 4.50 | 2.79 ± 4.22 | 5.50 ± 3.14 | 11.05 ± 3.65 | 10.29 ± 4.67 | 2.00 ± 2.63 | 2.69 ± 4.01 | 13.27 ± 3.08 | 5.62 ± 4.37 |
n = 28 | n = 28 | n = 14 | n = 14 | n = 21 | n = 21 | n = 16 | n = 16 | n = 26 | n = 26 | |
H. pylori-/NSAID+ | 0.00a± 0 | 0.00 ± 0 | 3.38 ± 3.07 | 3.54 ± 3.82 | 9.23 ± 3.64 | 9.57 ± 4.73 | 5.06 ± 5.52 | 3.44 ± 4.70 | 14.07 ± 2.01 | 4.47 ± 4.32 |
n= 14 | n = 14 | n = 13 | n = 13 | n = 20 | n = 20 | n = 18 | n = 18 | n = 15 | n = 15 | |
H. pylori+/NSAID+ | 11.00 ± 3.78 | 7.33 ± 4.13 | 3.75 ± 2.93 | 6.44 ± 5.17 | 5.93 ± 2.99 | 8.80 ± 3.76 | 4.18 ± 5.57 | 6.94 ± 5.30 | 13.78 ± 2.73 | 4.61 ± 4.64 |
n = 18 | n = 18 | n = 16 | n = 16 | n =19 | n = 19 | n = 17 | n = 17 | n = 18 | n = 18 | |
H. pylori-/NSAID- | 9.89 ± 4.17 | 7.63 ± 4.60 | 4.59 ± 3.77 | 4.00 ± 4.12 | 6.93 ± 4.00 | 8.00 ± 3.48 | 6.17 ± 4.69 | 3.94 ± 5.45 | 13.06 ± 4.06 | 8.00 ± 5.15 |
n = 19 | n = 19 | n = 17 | n = 17 | n =22 | n = 22 | n = 18 | n = 18 | n = 18 | n = 18 |
-
Citation: Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, Lawrence ES, Gagneux P, Kaur S, Sharma P, Batra SK, Ho SB. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or
Helicobacter pylori , NSAID associated peptic ulcers. World J Gastroenterol 2014; 20(40): 14913-14920 - URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14913